THE ROLE OF HYPERPROLACTINEMIA IN THE REMODELING OF JOINT STRUCTURES IN RHEUMATOID ARTHRITIS IN WOMEN
Keywords:
rheumatoid arthritis, prolactin, reproductive age.Abstract
In 61 women with RA of reproductive age, an increase in blood prolactin levels was found in 72.1% of cases, compared with healthy women. As the disease progresses, the amount of prolactin in the patients' blood increases, and as its level increases, the radiological signs of the disease progress. At the same time, fluctuations in its level in the blood are accompanied by the progression of osteitis, an increase in the number and volume of erosions in the joints, which indicates the involvement of hyperprolactinemia in the early remodeling of joint structures.
References
Adan N., Ledesma-Colunga M. G., Reyes-Lopez A. L., Martinez de la Escalera G., Clapp C Arthritis and prolactin: a phylogenetic viewpoint. Gen Comp Endocrinol. 2014; 203:132-136.
Croia C. et al. One year in review 2019: pathogenesis of rheumatoid arthritis //Clin exp rheumatol. – 2019. – Т. 37. – №. 3. – С. 347-357.
Gravallese E. M., Firestein G. S. Rheumatoid arthritis—common origins, divergent mechanisms //New England Journal of Medicine. – 2023. – Т. 388. – №. 6. – С. 529-542.
Mariani F. M. et al. Pathogenesis of rheumatoid arthritis: one year in review 2023 //Clin Exp Rheumatol. – 2023. – Т. 41. – №. 9. – С. 1725-1734.
Matkerimova N., Akhmedov K., Dzhusupov K. Trends in the prevalence and global burden of musculoskeletal diseases among adults: a narrative literature review of the past 10 years //Georgian medical news. – 2026. – №. 372. – С. 27-39.
Norbutoev O., Akhmedov K, Abdurakhmanova N. Treatment and Genotypic Characteristics of Patients with Rheumatoid Arthritis //BIO Web of Conferences. – EDP Sciences, 2025. – Т. 151. – С. 04030.
Raine C., Giles I. What is the impact of sex hormones on the pathogenesis of rheumatoid arthritis? //Frontiers in medicine. – 2022. – Т. 9. – С. 909879.
Rakhimova M. B., Akhmedov K.S., Rakhimova O. A. Association of PTPN22 rs2476601 (1858C> T) polymorphism with susceptibility and disease activity in rheumatoid arthritis: A case-control study from uzbekistan //IMRAS. – 2026. – Т. 9. – №. 4. – С. 65-74.
Studenic P. et al. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision //Annals of the rheumatic diseases. – 2023. – Т. 82. – №. 1. – С. 74-80.
Tang M. W., Reedquist K. A., Garcia S., Fernandez B. M., Codullo V., Vieira-Sousa E., et al. The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. Rheumatology (Oxford). 2016;55(12):2248-59.
Templ E., Koeller M., Riedl M., Wagner O., Graninger W., Luger A. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br J Rheumatol. 1996;35(4):350-6.
Горячев Д. В. и др. Прогностическое значение прогрессии рентгенологических изменений суставов при ревматоидном артрите //Научно-практическая ревматология. – 2008. – №. 2. – С. 26-34.
Коновалов К. М. и др. Оценка активности иммуновоспалительного процесса при ревматоидном артрите–клинические индексы и лабораторные маркеры: влияние инфекции COVID-19 //Пациентоориентированная медицина и фармация. – 2025. – №. 1. – С. 49-58.
Пузикова О. З. и др. Роль половых гормонов в регуляции врожденного иммунитета //Медицинское обозрение. – 2025. – Т. 9. – №. 2. – С. 119-124.
